(Reuters) — About 50,000 people are alive today because U.S. hospitals committed 17% fewer medical errors in 2013 than in 2010, government health officials said today.
Dept. of Health & Human Services (HHS)
HHS hits Covidien with subpoena over peripheral devices
BSX wins CE Mark, FDA approval for spinal cord stims | Regulatory news for the week of October 27, 2014
Boston Scientific wins CE Mark, FDA nod for spinal surgical leads
October 21, 2014 by Brad Perriello
Auditors: FDA needs to boost cybersecurity
Federal auditors have determined the FDA needs to ramp up its cybersecurity efforts in order to deter hackers.
Auditors for the U.S. Health & Human Services Dept.’s Inspector General’s Office tested many of the FDA’s IT systems in the wake of a security breach last October that exposed approximately 14,000 user accounts.
Medicare: Medical device companies paid out $200m to physicians last year
Diabetes: Patients hack glucose monitors | MassDevice.com On Call
MASSDEVICE ON CALL — More and more patients are hacking into their glucose monitors to add functionality, with medical device companies lagging behind as they work their own improvements through the FDA, according to the Wall Street Journal.
Boston Scientific discloses HHS probe into Cognis, Teligen ICDs
Boston Scientific (NYSE:BSX) said it received a subpoena from the U.S. Health & Human Services Dept. over its Cognis and Teligen implantable cardiac defibrillators.
Abiomed reveals HHS probe into provider payments
Regulators tout record $4.3B in recovered healthcare fraud | MassDevice.com On Call
MASSDEVICE ON CALL — Healthcare and Justice Dept. regulators hit a new record high in recovered healthcare dollars, with $4.3 billion returned to federal health programs in 2013.
That’s a return of more than $8 for every $1 spent on federal Health Care Fraud and Abuse Control Programs, according to McClatchy DC.
CareFusion pays out $41M in ChloraPrep settlement
CareFusion (NYSE:CFN) said it closed out the $41 million settlement of a 2-year federal investigation into the marketing of its ChloraPrep antiseptic skin preparation wipes.
Medical device tax: Why low Obamacare enrollment numbers cut a hole in the argument against repeal
The medical device industry this week may have received the strongest argument yet for repealing the 2.3% medical device excise tax.